Amphotericin B formulations: a comparative review of efficacy and toxicity.
about
Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?Leishmaniasis revisited: Current aspects on epidemiology, diagnosis and treatmentCryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness AnalysisEfficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.Polyuria in a Patient with Aspergillus Infection.Clinical Translation of Nanomedicine.Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B.Gallic acid/hydroxypropyl-β-cyclodextrin complex: Improving solubility for application on in vitro/ in vivo Candida albicans biofilms.Bioengineered vaults: self-assembling protein shell-lipophilic core nanoparticles for drug delivery.Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes.Diet modification and metformin have a beneficial effect in a fly model of obesity and mucormycosis.Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments.Safety and efficacy of amphotericin-B deoxycholate inhalation in critically ill patients with respiratory Candida spp. colonization: a retrospective analysis.Effect of Amphotericin B Nanodisks on Leishmania major Infected Mice.Cryptococcus neoformans Yap1 is required for normal fluconazole and oxidative stress resistanceEffect of the crude extract of Eugenia uniflora in morphogenesis and secretion of hydrolytic enzymes in Candida albicans from the oral cavity of kidney transplant recipientsIdentification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitorsEfficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective StudyRetrospective Analysis on the Use of Amphotericin B Lipid Complex in Neutropenic Cancer Patients with Suspected Fungal Infections in Lebanon, a Single Center Experience and Review of International Guidelines.Drug-induced acute kidney injury in neonatesAntimycotic Activity and Genotoxic Evaluation of Citrus sinensis and Citrus latifolia Essential Oils.Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.The Role of Signaling via Aqueous Pore Formation in Resistance Responses to Amphotericin BNanotherapeutics in the EU: an overview on current state and future directions.Antifungal and antiviral products of marine organisms.Prediction of the effect of formulation on the toxicity of chemicals.Antifungal drug development: challenges, unmet clinical needs, and new approaches.Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature.Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?New perspectives for leishmaniasis chemotherapy over current anti-leishmanial drugs: a patent landscape.Understanding Drug Release Data through Thermodynamic AnalysisSusceptibility pattern of Candida albicans isolated from Iranian patients to antifungal agents.Systemic Antifungal Agents: Current Status and Projected Future Developments.New facets of antifungal therapy.Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.Potential Use of Alginate-Based Carriers As Antifungal Delivery SystemLiposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use.The antifungal pipeline: a reality check.A multicenter phase 2 study of empirical low-dose liposomal amphotericin B in patients with refractory febrile neutropenia.
P2860
Q26740363-35B17B74-7ECD-46BA-9FA7-C1ABBC92D0CBQ28082283-3FD8DD9B-92C3-48A0-AF67-E2F0D81FA733Q28274334-B70BC40F-2781-4604-999B-D9F3371313ABQ30240770-4EA70EFF-C2B1-4701-8ED7-196D29D14A45Q30252974-C26030BC-246F-4D28-88C4-CF7926D1A519Q30355939-7E2B8732-0049-4DE8-8C8B-1D17B27C5514Q33409652-3FB94D58-981E-4B6C-84D7-E3DADF723303Q33898241-9257AB95-2E68-4EC7-8D98-1B4AB82BAE87Q34104328-F761F0AC-AA13-400A-A8EC-CB8626EDFC55Q34145535-3111BCD7-CC90-43B9-94B3-FEA0C088CEFDQ34277496-9A5465A8-B12E-45C3-8974-23789C96C1E0Q34417313-C0ED9364-615A-45F7-AD28-DB3B4609A381Q34422915-C2542079-50E6-45E4-BAB6-E5CF1BD4E40BQ34889020-28C3F902-3170-4106-94A2-78AA350C4833Q34943653-701397B2-B851-473B-A0B1-03743E770E1BQ35555192-F07E97D8-59F9-4F34-9C22-190A7A8DA71EQ36028611-F4E9A4BD-50F7-4A7F-9531-27430323F2EFQ36359258-B97BA146-FB76-49B8-A8F5-5435DC7CA264Q36427453-1DF94757-BF29-4CE7-9446-806733978387Q36776390-1DEC985C-059E-4131-8C61-6E742E0679EBQ36860540-58CD7BA9-D98A-4A56-98C0-1212BF847F35Q36868273-A3EA5F3C-341C-4DFF-9D8B-438FC043D625Q37203821-CA029396-56B8-4D54-AB71-C33B24C7EE5CQ37601242-9DAFE356-31FE-4491-89B2-D56753C1AD10Q37634178-62A247DC-23C8-44B9-ACEF-DD48504C85F1Q37643371-DF9CE6F7-1503-4F87-98F6-5EB1B7BE398FQ37717926-C48E7540-FD7F-46C3-B4B8-AFA2AEE3C7C7Q38193337-9381FF25-EE62-42D7-97AA-E163D8E0D5C6Q38211509-CD76503C-9ABB-45F1-8640-261D864EC95EQ38236893-57A764B1-DD23-40CC-868D-3ED9AE3739C8Q38296306-0A5A8BE1-31DF-4886-A927-F64313E2A453Q38643492-09D179BD-069B-413C-B50C-2BC7A48AEA70Q38691900-F4BA376D-F1FF-47A1-914C-D40578E6814BQ38796140-46BD2CEF-6C68-43E6-962A-C8F281ED6121Q38797864-691EB980-7B55-4219-8A34-FEC577829854Q38851467-4B01E1D5-CCFE-4BBE-9A2F-6D0F035FAD94Q39134282-EB731A77-31A3-496A-86BF-B99073D9AB79Q39196802-0D585C6E-C0C0-42B8-90D4-3E1B96BFF4FBQ39299949-5274D1FD-92B2-44A7-8C37-F5CA9DB16BF8Q39328808-17D01555-5FE1-47F3-89B5-E655A6BD56BB
P2860
Amphotericin B formulations: a comparative review of efficacy and toxicity.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Amphotericin B formulations: a comparative review of efficacy and toxicity.
@en
type
label
Amphotericin B formulations: a comparative review of efficacy and toxicity.
@en
prefLabel
Amphotericin B formulations: a comparative review of efficacy and toxicity.
@en
P1433
P1476
Amphotericin B formulations: a comparative review of efficacy and toxicity.
@en
P2093
Richard J Hamill
P2888
P304
P356
10.1007/S40265-013-0069-4
P577
2013-06-01T00:00:00Z
P6179
1034177761